[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5037 

# __Lack of effective antiviral drug and vaccine__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Investment in research for antiviral drug and vaccine development](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6910.md)

## Name of the risk

High risk of uncontrolled disease spread

## People affected by this risk

* [General public](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_29.md)
* [Scientific community](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_348.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Biotechnology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2293.md)
* [Nanotechnology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_5141.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

